Welpar Pharmbizz Profile
Key Indicators
- Authorised Capital ₹ 18.50 Cr
- Paid Up Capital ₹ 13.40 Cr
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.00 Cr
- Revenue Growth -37.39%
- Profit Growth -342.69%
- Ebitda -49.97%
- Net Worth -9.60%
- Total Assets 19.38%
About Welpar Pharmbizz
Welpar Pharmbizz Limited (WPL) is a Public Limited Indian Non-Government Company incorporated in India on 10 May 2018 (Six years and eight months 25 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 18.50 Cr and a paid-up capital of Rs 13.40 Cr.
The company currently has active open charges totaling ₹8.00 Cr.
The Key Managerial Personnel (KMP) at Welpar Pharmbizz Limited India is Manish Chhajed as CFO. Kiran Paras, Manish Chhajed, Dipesh Chhajed, and Two other members serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999MH2018PLC309197
-
Company No.
309197
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
10 May 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Welpar Pharmbizz?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Dipesh Chhajed | Managing Director | 10-May-2018 | Current |
Manish Chhajed | CFO | 10-May-2018 | Current |
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Aakash Hinger | Director | 01-Aug-2018 | Current |
Kiran Paras | Whole-Time Director | 10-May-2018 | Current |
Manish Chhajed | Director and Cfo | 10-May-2018 | Current |
Shubham Salvi | Director | 01-Aug-2018 | Current |
Financial Performance of Welpar Pharmbizz.
Welpar Pharmbizz Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 37.39% decrease. The company also saw a substantial fall in profitability, with a 342.69% decrease in profit. The company's net worth dipped by a decrease of 9.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Welpar Pharmbizz?
In 2019, Welpar Pharmbizz had a promoter holding of 66.23% and a public holding of 33.77%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹8.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 8.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
04 Jan 2019 | Others | ₹8.00 Cr | Open |
How Many Employees Work at Welpar Pharmbizz?
Welpar Pharmbizz has a workforce of 22 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Welpar Pharmbizz, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Welpar Pharmbizz's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.